Overview

Study of Sodium Bicarbonate in Restoring Blocked Catheters

Status:
Withdrawn
Trial end date:
2021-09-02
Target enrollment:
0
Participant gender:
All
Summary
This is a study looking at the use of sodium bicarbonate to restore the flow of blocked central line devices in patients with blood cancers. Central line devices uses thin tubes that are placed into a vein in the body to give medicines, fluids, nutrients, blood products, etc. Sometimes, the lines become blocked. The standard procedure to get the line working again is to use alteplase, a protein that dissolves blood clots. While blood clotting is one cause of a blocked line, other reasons included the formation of calcium deposits. Sodium bicarbonate is routinely used in the treatment of patients receiving chemotherapy. Sodium bicarbonate is a liquid drug which is capable of dissolving protein and calcium deposits. This study will compare whether sodium bicarbonate works just as well as alteplase to recover the function of a blocked line.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Health Network, Toronto
Treatments:
Pharmaceutical Solutions
Tissue Plasminogen Activator
Criteria
Inclusion Criteria:

- Hematology patients with indwelling CVC/PICC line.

- Patients continuing to receive chemotherapy treatment for consolidation,
intensification and maintenance regimens in hematological malignancies such as in
acute leukemia, lymphoma, myelodysplastic syndrome, supportive care measures using
blood products, ongoing anti-infective treatments, and nutrition.

- Patients whose CVC/PICC line becomes obstructed during routine care are being
identified and presented to attending physician and pharmacist.

- Mechanical obstruction having been ruled out by visual inspection and manipulation of
the patient's posture or extremities or both.

Exclusion Criteria:

- Patients with hemodialysis line occlusions

- Anyone with documentation of prior history of alteplase allergy or hypersensitivity
reactions